AIGR Gene Hypothesis Deep Research — Rat ALDH1L1 (P28037)

Focus: Cofactor Specificity and Mitochondrial Localization

Hypothesis under evaluation: Rat ALDH1L1 has NAD⁺-dependent aldehyde dehydrogenase activity (GO:0004029) and localizes to mitochondria (GO:0005739).

Focus type: function_assignment · Gene: Aldh1l1 (rat, NCBITaxon:10116) · UniProt: P28037 (AL1L1_RAT, "Cytosolic 10-formyltetrahydrofolate dehydrogenase", EC 1.5.1.6)

Summary

This report evaluates a two-part function-assignment hypothesis for rat ALDH1L1 and finds that both clauses fail as literally worded, each for a well-characterized and independently verifiable reason. The seed instruction to evaluate the cofactor and localization claims separately, and to distinguish ALDH1L1 from its mitochondrial paralog ALDH1L2, is essential — and following it resolves the hypothesis cleanly.

On cofactor specificity, direct enzymology on the rat protein shows the aldehyde dehydrogenase activity is NADP⁺-dependent, not NAD⁺-dependent. Purified rat liver cytosolic 10-formyltetrahydrofolate dehydrogenase oxidizes propanal with Km(NADP⁺) = 46 µM, and the rat crystal structure identifies a Gln600 water-mediated contact with the 2′-phosphate of NADP that structurally enforces "specificity of the enzyme for NADP over NAD." Consequently GO:0004029 (aldehyde dehydrogenase (NAD⁺) activity) is over-annotated — it is present only by orthology inference and is contradicted by primary rat data. Moreover, even the correctly-cofactored NADP⁺-aldehyde activity is a promiscuous in-vitro property of the C-terminal ALDH-like domain acting on small surrogate substrates, not a physiological aldehyde-detoxification function.

On localization, rat ALDH1L1 is the cytosolic enzyme (its UniProt name literally begins "Cytosolic…", with IDA support for GO:0005829). The mitochondrial 10-formyl-THF dehydrogenase is a distinct paralog, ALDH1L2, the product of a separate gene that arose by duplication before the emergence of bony fish, and which carries an N-terminal mitochondrial presequence that ALDH1L1 lacks. GO:0005739 (mitochondrion) on ALDH1L1 is supported only by phylogenetic inference (IBA) and most plausibly reflects paralog carry-over. The core, physiologically supported molecular function — confirmed by knockout phenotypes that map to folate/glycine one-carbon metabolism — is GO:0016155 (formyltetrahydrofolate dehydrogenase activity), cytosolic and NADP⁺-dependent. The overall curation verdict is therefore over-annotated / refuted on both counts as literally stated, with accurate replacement terms already present on the record.

Executive Judgment

Verdict: Over-annotated / refuted on both counts, as literally stated.

1. GO:0004029 "aldehyde dehydrogenase (NAD⁺) activity" — REFUTED (wrong cofactor) + non-core (in-vitro promiscuity). Direct kinetic and structural studies of the rat enzyme show the aldehyde dehydrogenase activity is NADP⁺-dependent (Km NADP⁺ = 46 µM; structural selectivity for NADP over NAD via Gln600). Short-chain-aldehyde (propanal) oxidation is a promiscuous in-vitro activity of the ALDH-like C-terminal domain, not a supported physiological function. The correct cofactor term, GO:0033721 "aldehyde dehydrogenase (NADP⁺) activity", is already present (IDA). GO:0004029 is attached only by ISO (orthology-inferred) evidence and is contradicted by primary rat data.

2. GO:0005739 "mitochondrion" — WEAKLY SUPPORTED / likely paralog carry-over. The experimentally supported location is cytosol (GO:0005829, IDA). The mitochondrial 10-formyl-THF dehydrogenase is a distinct paralog, ALDH1L2 (~74% identity; arose by duplication before bony fish). GO:0005739 on ALDH1L1 rests only on IBA (phylogenetic inference) and most plausibly reflects carry-over from ALDH1L2. No experimental rat mitochondrial ALDH1L1 pool was found.

Most important caveat: The two GO terms must be evaluated separately. The enzyme is a genuine ALDH-superfamily oxidoreductase with real, physiologically relevant dehydrogenase chemistry — but that chemistry is NADP⁺-dependent and cytosolic, and its textbook ALDH aldehyde-oxidation activity is an in-vitro side reaction. The issue is not that the annotations are nonsense; it is that both use the wrong sub-term (NAD⁺ vs NADP⁺) or wrong compartment (mitochondrion vs cytosol) relative to the direct rat evidence.

Key Findings

Finding 1 — The aldehyde dehydrogenase activity is NADP⁺-dependent, not NAD⁺, and is an in-vitro promiscuous activity of the C-terminal domain

The single most decisive line of evidence is direct enzymology on the rat protein. Cook & Wagner (PMID: 7646059) purified rat liver cytosolic 10-formyltetrahydrofolate dehydrogenase (10-FTHFDH) and showed it "catalyzed NADP(⁺)-dependent oxidation of propanal and the hydrolysis of p-nitrophenyl acetate (pNPA) in a similar fashion to ALDH." Initial-rate studies gave Km = 46 µM for NADP⁺ and 636 µM for propanal, and reported no NAD⁺-dependent activity. This is a quantitative cofactor assay in the exact organism named by the hypothesis, and it directly contradicts an NAD⁺-specificity assignment.

The cofactor preference has a defined structural basis. Crystal structures of the rat C-terminal domain (PMID: 17302434) reveal "a new mode of binding of the 2′-phosphate group of NADP via a water-mediated contact with Gln600 that may contribute to the specificity of the enzyme for NADP over NAD." An active site tuned to accept the 2′-phosphate of NADP is not an NAD⁺-specific enzyme. A companion mutagenesis/structural study (PMID: 21540484) describes the C-terminal domain flatly as "an NADP(⁺)-dependent oxidoreductase," with Cys707/Glu673 controlling coenzyme binding and redox sensing.

Finally, the phylogenetic/enzymology review (PMID: 21215736) states the ALDH-homologous domain "enables FDH to catalyze the NADP(⁺)-dependent conversion of short-chain aldehydes to corresponding acids in vitro." Both the cofactor and the in-vitro qualifier are explicit. The short-chain-aldehyde activity is best understood as catalytic promiscuity of an ALDH-fold domain that, in the intact fusion enzyme, performs the final formyl→CO₂ oxidation of 10-formyl-THF turnover — not an independent physiological aldehyde pathway.

Finding 2 — Rat ALDH1L1 is cytosolic; the mitochondrial FDH is the paralog ALDH1L2

UniProt P28037 is named "Cytosolic 10-formyltetrahydrofolate dehydrogenase," and its cytosol annotation (GO:0005829) carries IDA (direct assay) support, whereas the mitochondrion annotation (GO:0005739) carries only IBA (phylogenetically inferred) support. The original rat enzyme was characterized from liver cytosol (PMID: 7646059).

The Krupenko laboratory resolved the compartment question explicitly. In Enzymatic properties of ALDH1L2, a mitochondrial 10-formyltetrahydrofolate dehydrogenase (PMID: 21238436), they describe ALDH1L1 as "an abundant cytosolic enzyme of folate metabolism" and report that the "mitochondrial isoform of FDH (mtFDH) … is the product of a separate gene, ALDH1L2." The mitochondrial activity therefore belongs to a different gene product. The phylogenetic analysis (PMID: 21215736) dates the split: "the vertebrate ALDH1L2 gene arose from a duplication event of the ALDH1L1 gene prior to the emergence of osseous fish" (>500 Mya). ALDH1L1 and mitochondrial ALDH1L2 are ancient, separate paralogs, which is exactly the setup in which phylogenetic (IBA) annotation transfer produces a spurious mitochondrion term on the cytosolic paralog.

Finding 3 — Sequence-level proof: ALDH1L1 lacks the mitochondrial presequence that defines ALDH1L2

A direct comparison of UniProt sequences (own analysis; provenance CSV aldh1l1_vs_aldh1l2_Nterm_presequence.csv) makes the paralog-carry-over interpretation concrete. Rat ALDH1L1 (P28037) and human ALDH1L1 (O75891) begin immediately at the folate-binding/hydrolase domain (MKIAVIGQSLFGQEVY…), with no N-terminal extension and no annotated transit peptide. In contrast, human ALDH1L2 (Q3SY69) and rat ALDH1L2 (A0ABK0LNR0) carry a 27-residue N-terminal extension preceding the shared catalytic-domain anchor IGQSLFGQEVY:

ALDH1L1 (rat P28037):   ------------------------- MKIAVIGQSLFGQEVY...   (no presequence)
ALDH1L1 (human O75891): ------------------------- M-KIAVIGQSLFGQEVY... (no presequence)
ALDH1L2 (human Q3SY69): MLRRGSQALRRFSTGRVYFKNKLKLAL ... IGQSLFGQEVY   (+27 aa presequence)
ALDH1L2 (rat A0ABK...): MLWRGSQALRHFSTGRVYFKNKLKLAL ... IGQSLFGQEVY   (+27 aa presequence)

The ALDH1L2 extension has the classic cleavable mitochondrial presequence signature: Arg/Lys-rich, net positive charge (+6 to +8), and 0 acidic residues. In human ALDH1L2 it is a documented Transit peptide (residues 1–19). ALDH1L1 has no equivalent segment. This is the physical basis for why one paralog goes to mitochondria and the other stays cytosolic, and it independently corroborates that a mitochondrion annotation on ALDH1L1 is misassigned. (Limitation: rat ALDH1L2 presequence cleavage is inferred by homology to human.)

Finding 4 — In-vivo loss-of-function maps to folate/glycine one-carbon metabolism, confirming the aldehyde activity is non-core

The physiological (core) function is established by knockout biology, not in-vitro promiscuity. In Cytosolic 10-formyltetrahydrofolate dehydrogenase regulates glycine metabolism in mouse liver (PMID: 31624291), ALDH1L1 "metabolizes 10-formyltetrahydrofolate to produce tetrahydrofolate (THF). This reaction might have a regulatory function towards reduced folate pools, de novo purine biosynthesis, and the flux of folate-bound methyl groups." A folate-withdrawal study (PMID: 35629957) reiterates that ALDH1L1 "regulates the overall flux of folate-bound one-carbon groups by converting 10-formyltetrahydrofolate to tetrahydrofolate and CO₂," and knockout of the putative tumor suppressor reprograms metabolism to accelerate liver tumor growth (PMID: 34203215). No knockout study reports a free short-chain-aldehyde detoxification phenotype. The physiological readout is folate one-carbon metabolism, confirming that the aldehyde-dehydrogenase terms describe a domain-level in-vitro capability, not the physiological role.

Mechanistic Model / Interpretation

ALDH1L1 (FDH) is a homotetrameric fusion of three domains (PMID: 18848533), and understanding this architecture dissolves the apparent conflict in the seed hypothesis:

   N-terminal domain          Intermediate linker            C-terminal domain
   (residues 1–310)           (residues 311–399)             (residues 400–902)
   10-formyl-THF hydrolase  →  4'-phosphopantetheine     →   ALDH-fold, NADP+-dependent
   removes formyl group        "swinging arm" carries         oxidizes formyl → CO2
                       formyl between centers
|                                                            |
└──────────── coupled overall reaction ─────────────────────┘
10-formyl-THF  +  NADP+   →   THF  +  CO2  +  NADPH

• The C-terminal ALDH-fold domain is a genuine aldehyde dehydrogenase homolog. In isolation, and on artificial substrates (propanal, p-nitrophenyl acetate), it displays classic ALDH chemistry — but NADP⁺-dependent, because of the Gln600 2′-phosphate contact. This is the source of the "aldehyde dehydrogenase activity" annotation. It is real but promiscuous and non-physiological when applied to free short-chain aldehydes.
• In the intact enzyme, that same domain performs the final formyl→CO₂ oxidation step of the folate reaction, using the phosphopantetheine arm (PMID: 17884809) to receive the formyl group from the N-terminal hydrolase. The physiological substrate is a folate-tethered formyl, not a free aldehyde.

Two distinct annotation errors follow directly from mis-reading this biology:

The two errors share a root cause: ALDH1L1 is being annotated as though it were a generic ALDH and/or its mitochondrial paralog ALDH1L2, rather than as the specific cytosolic folate enzyme it is.

Evidence Base

GO Curation Implications (leads — require curator verification)

Bottom line for the curator: the seed hypothesis, as worded (NAD⁺ activity + mitochondrion), should not be adopted. Both terms map onto real biology but with the wrong cofactor sub-term and the wrong compartment; the accurate annotations (NADP⁺ ALDH, cytosol, formyl-THF dehydrogenase) already exist on the record. Avoid a generic "protein binding" fallback — the informative MF term (GO:0016155) is well supported.

Mechanistic Scope

The immediate molecular function of ALDH1L1 is a homotetrameric, three-domain fusion enzyme (N-terminal 10-formyl-THF hydrolase; intermediate 4′-phosphopantetheine acyl-carrier linker; C-terminal ALDH-homologous domain). The physiological reaction is NADP⁺-dependent oxidation of the THF-bound formyl group to CO₂ (10-formyl-THF → THF + CO₂ + NADPH), i.e., formyltetrahydrofolate dehydrogenase (EC 1.5.1.6) — regenerating THF and NADPH in cytosolic one-carbon metabolism. The "aldehyde dehydrogenase" chemistry on free short-chain aldehydes (e.g., propanal) is the same catalytic C-terminal domain acting on a small surrogate substrate in vitro — a demonstration of the ALDH-like acyl-transfer mechanism (Cys707 thiohemiacetal → thioester), not an independent physiological aldehyde-detox pathway.

Downstream/pleiotropic effects — tumor-suppressor behavior, folate-pool regulation, glycine metabolism, lipid homeostasis links, astrocyte-marker usage — are consequences of the folate function, not the tested activity. The in-vivo loss-of-function support (Aldh1l1-KO reprogramming of glycine and one-carbon metabolism) confirms that the ALDH aldehyde-oxidation activity is non-core relative to the folate function.

Conflicts and Alternatives

• Paralog confusion (primary alternative): Mitochondrial 10-formyl-THF dehydrogenase activity and mitochondrial localization belong to ALDH1L2 (separate gene). GO:0005739 on ALDH1L1 is the expected signature of phylogenetic (IBA) carry-over across the paralog pair.
• Cofactor sub-term drift: Automated/orthology inference maps ALDH1L1 to the generic ALDH family, dominated by NAD⁺-using members; this likely produced the ISO GO:0004029 NAD⁺ term despite rat data showing NADP⁺ specificity.
• In-vitro vs physiological: Reviews explicitly flag the aldehyde-oxidation as "in vitro"; human ALDH1L2 lacked detectable ALDH activity even though it performs the folate reaction — underscoring that the ALDH aldehyde activity is a domain property, not necessarily physiologically deployed.
• Isoform/secondary pools: No primary evidence for a mitochondrial rat ALDH1L1 pool was located; a minor pool cannot be strictly excluded, but none is documented, and the absent presequence makes it unlikely.
• Sequence-level confirmation: A direct N-terminal comparison shows mitochondrial targeting is encoded by the ALDH1L2 presequence (Arg-rich, acidic-free, ~27 aa; documented human Transit peptide 1–19) and is entirely absent from ALDH1L1 — independently corroborating that GO:0005739 on ALDH1L1 is paralog carry-over, not a genuine import signal.

Limitations and Knowledge Gaps

1. Is any NAD⁺-dependent activity ever detectable for rat ALDH1L1? Checked: Cook & Wagner report only NADP⁺ activity; no NAD⁺ kinetics given (absence of evidence, not a formal negative). Matters because GO:0004029 asserts NAD⁺. Resolve with a side-by-side NAD⁺ vs NADP⁺ kcat/Km assay on recombinant rat enzyme.
2. Direct rat localization data. Checked: UniProt cytosol is IDA, but the strongest explicit "cytosolic vs mitochondrial separate gene" statements are human-focused. Matters for the mitochondrion CC. Resolve with rat subcellular fractionation / immunofluorescence that discriminates ALDH1L1 from ALDH1L2.
3. Provenance of the IBA mitochondrion call. Which reference-genome members seeded GO:0005739? A curator check of the PAINT/IBA tree would confirm ALDH1L2-driven carry-over.
4. Current evidence codes were inferred from the annotation pattern, not re-pulled live; the ISO status of GO:0004029 and IBA status of GO:0005739 should be verified in the live GO/UniProt record before editing.
5. Isoform coverage was not exhaustive; a rare N-terminally extended ALDH1L1 isoform cannot be fully excluded, though none is documented.

Discriminating Tests

• Cofactor competition assay: measure propanal (or 10-formyl-THF) oxidation vs [NAD⁺] and [NADP⁺]; prediction: activity only with NADP⁺ (Km≈46 µM), negligible with NAD⁺ → discriminates GO:0004029 vs GO:0033721.
• Gln600 mutagenesis: removing the 2′-phosphate water contact should relax NADP-over-NAD selectivity, confirming the structural basis of specificity.
• Compartment-resolved proteomics/IF in rat tissue with paralog-discriminating peptides/antibodies → tests GO:0005739 vs GO:0005829.
• Presequence-swap import assay: append the ALDH1L2 27-aa presequence to ALDH1L1 and test mitochondrial import → predicted to redirect ALDH1L1 to mitochondria, confirming the presequence is the sole compartment determinant.
• Isolated-domain vs holoenzyme kinetics for aldehyde vs 10-formyl-THF → confirms the aldehyde activity is a C-terminal-domain in-vitro property (non-core).
• Metabolomic phenotyping of Aldh1l1-KO for aldehyde adducts: predicted null (folate/glycine changes only), confirming aldehyde-detox is non-physiological.

Curation Leads (verify)

• Candidate action 1: Remove/deprecate GO:0004029 (NAD⁺ ALDH, ISO); if a cofactor MF beyond formyl-THF dehydrogenase is wanted, keep GO:0033721 (NADP⁺ ALDH, IDA) with an in-vitro/non-core note. Refs to verify: PMID 7646059 (Km NADP⁺ 46 µM), 17302434 (Gln600 NADP>NAD), 21215736 ("in vitro").
• Candidate action 2: Remove or down-weight GO:0005739 (mitochondrion, IBA) as paralog carry-over from ALDH1L2; keep GO:0005829 (cytosol, IDA) as primary. Refs to verify: PMID 21238436, 21215736; own presequence analysis.
• Candidate core MF/BP: emphasize GO:0016155 formyltetrahydrofolate dehydrogenase + NADPH regeneration / 10-formyl-THF catabolism as the primary function. Refs to verify: PMID 17884809, 31624291, 35629957.
• Suggested curator question: "Does GO:0004029 on P28037 originate from ISO to a NAD⁺-preferring ALDH ortholog, and should it be replaced by the NADP⁺ term given direct rat kinetics? Does GO:0005739 originate from IBA seeded by ALDH1L2?"

All items above are leads requiring curator verification; snippets are drawn verbatim from the cited abstracts.

Artifacts

• OpenScientist aldh1l1 vs aldh1l2 Nterm presequence
• OpenScientist final report
• OpenScientist final report